rs587776629
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004589.4(SCO1):c.364_364+1delAG(p.Lys122fs) variant causes a frameshift, splice donor, splice region, intron change. The variant allele was found at a frequency of 0.000116 in 1,600,322 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004589.4 frameshift, splice_donor, splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCO1 | NM_004589.4 | c.364_364+1delAG | p.Lys122fs | frameshift_variant, splice_donor_variant, splice_region_variant, intron_variant | 2/6 | ENST00000255390.10 | NP_004580.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCO1 | ENST00000255390.10 | c.364_364+1delAG | p.Lys122fs | frameshift_variant, splice_donor_variant, splice_region_variant, intron_variant | 2/6 | 1 | NM_004589.4 | ENSP00000255390.5 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152066Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251236Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135814
GnomAD4 exome AF: 0.000113 AC: 163AN: 1448256Hom.: 0 AF XY: 0.000108 AC XY: 78AN XY: 721702
GnomAD4 genome AF: 0.000151 AC: 23AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74278
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 18, 2024 | Frameshift variant that results in protein truncation and unstable mRNA in a gene for which loss-of-function is a known mechanism of disease (PMID: 11013136); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 11013136) - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 26, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 28, 2022 | This sequence change creates a premature translational stop signal (Splice site) in the SCO1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCO1 are known to be pathogenic (PMID: 11013136, 23878101). This variant is present in population databases (rs745552237, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with cytochrome c oxidase deficiency and/or SCO1-related conditions (PMID: 11013136). It has also been observed to segregate with disease in related individuals. This variant is also known as c.364_364+1del, △GA; nt 363–364. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Mitochondrial complex 4 deficiency, nuclear type 4 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2000 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 18, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at